This was somewhat of a first for the US FDA to trust Chinese data. Shenzhen Chipscreen Bio sciences Ltd. was also awarded the Most Valued Partner for Roche R&D Center. Oncology drugs are one of their primary focuses, with individuals trained here in the US and returning to China to create their...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-15-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, FDA, Oncology, R and D, China pharma, Chipscreen, biosciences, HUYA
American Society of Clinical Oncology and Blue Cross/Blue Shield of Michigan will collect cancer information from 11 oncology practices in Michigan. Each physician will be paid around $3000.00 for their time in for the collection process. This is good for the exchange of information...
CBS is doing a special report this week on drugs for cancer. This video has an interview with the Head of Oncology from the FDA and what their process is to approve drugs for cancer....and an interview with one of the Biotech companies who make the drugs explains that the US requires a whole new clinical...